Department of Health and Community Sciences, University of Exeter, St Lukes Campus, Heavitree Road, Exeter, EX1 2LU, UK.
Centre for Cancer Screening, Prevention and Early Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, London, EC1M 6BQ, UK.
J Ovarian Res. 2024 Aug 26;17(1):173. doi: 10.1186/s13048-024-01490-5.
CA-125 testing is a recommended first line investigation for women presenting with possible symptoms of ovarian cancer in English primary care, to help determine whether further investigation for ovarian cancer is needed. It is currently not known how well the CA-125 test performs in ovarian cancer detection for patients from different ethnic groups.
A retrospective cohort study utilising English primary care data linked to the national cancer registry was undertaken. Women aged ≥ 40 years with a CA-125 test between 2010 and 2017 were included. Logistic regression predicted one-year ovarian cancer incidence by ethnicity, adjusting for age, deprivation status, and comorbidity score. The estimated incidence of ovarian cancer by CA-125 level was modelled for each ethnic group using restricted cubic splines.
The diagnostic performance of CA-125 differed for women from different ethnicities. In an unadjusted analysis, predicted CA-125 levels for Asian and Black women were higher than White women at corresponding probabilities of ovarian cancer. The higher PPVs for White women compared to Asian or Black women were eliminated by inclusion of covariates.
The introduction of ethnicity-specific thresholds may increase the specificity and PPVs of CA-125 in ovarian cancer detection at the expense of sensitivity, particularly for Asian and Black women. As such, we cannot recommend the use of ethnicity-specific thresholds for CA-125.
在英国初级保健中,CA-125 检测被推荐作为疑似卵巢癌症状的女性的一线检查,以帮助确定是否需要进一步进行卵巢癌检查。目前尚不清楚 CA-125 检测在检测不同种族患者的卵巢癌方面的表现如何。
利用英国初级保健数据与国家癌症登记处进行了回顾性队列研究。纳入年龄≥40 岁、2010 年至 2017 年间进行 CA-125 检测的女性。采用逻辑回归按族裔预测一年卵巢癌发病率,调整年龄、贫困状况和合并症评分。使用受限立方样条为每个族裔组对 CA-125 水平预测的卵巢癌发生率进行建模。
CA-125 对不同族裔女性的诊断性能不同。在未调整分析中,亚洲和黑人女性的预测 CA-125 水平在相应的卵巢癌概率下高于白人女性。通过纳入协变量,可以消除白人女性与亚洲或黑人女性相比更高的阳性预测值。
引入种族特异性阈值可能会提高 CA-125 在卵巢癌检测中的特异性和阳性预测值,但代价是敏感性降低,尤其是对于亚洲和黑人女性。因此,我们不能推荐使用 CA-125 的种族特异性阈值。